Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00594139

Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

An Open Label Multi-center Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Tengion · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Subjects with non-neurogenic over-active bladder will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will increase functional capacity and thereby reduce the number of micturition episodes per day in subjects with non-neurogenic over active bladder and urge predominant incontinence.

Detailed description

Subjects with non-neurogenic over-active bladder and urge predominant incontinence who are intolerant to medical therapy or have persistence of symptoms despite medical therapy and require augmentation cystoplasty will be enrolled. The hypothesis is that augmentation cystoplasty using an autologous neo-bladder construct will increase functional capacity and thereby reduce the number of micturition episodes per day in subjects with non-neurogenic over active bladder and urge predominant incontinence.

Conditions

Interventions

TypeNameDescription
BIOLOGICALAutologous neobladder constructprovision of an autologous neo-bladder construct

Timeline

Start date
2008-01-01
Primary completion
2008-01-01
Completion
2008-01-01
First posted
2008-01-15
Last updated
2018-06-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00594139. Inclusion in this directory is not an endorsement.